KBC Group’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,273
| Closed | -$85K | – | 1721 |
|
|
2025
Q1 | $85K | Hold |
1,273
| – | – | ﹤0.01% | 1575 |
|
|
2024
Q4 | $70K | Buy |
1,273
+600
| +89% | +$33K | ﹤0.01% | 1729 |
|
|
2024
Q3 | $40K | Hold |
673
| – | – | ﹤0.01% | 1779 |
|
|
2024
Q2 | $43K | Hold |
673
| – | – | ﹤0.01% | 1696 |
|
|
2024
Q1 | $47K | Hold |
673
| – | – | ﹤0.01% | 1589 |
|
|
2023
Q4 | $37K | Hold |
673
| – | – | ﹤0.01% | 1702 |
|
|
2023
Q3 | $39K | Sell |
673
-408
| -38% | -$23.6K | ﹤0.01% | 1635 |
|
|
2023
Q2 | $58K | Hold |
1,081
| – | – | ﹤0.01% | 1327 |
|
|
2023
Q1 | $43K | Hold |
1,081
| – | – | ﹤0.01% | 1412 |
|
|
2022
Q4 | $43K | Hold |
1,081
| – | – | ﹤0.01% | 1426 |
|
|
2022
Q3 | $35K | Hold |
1,081
| – | – | ﹤0.01% | 1458 |
|
|
2022
Q2 | $32K | Buy |
+1,081
| New | +$32K | ﹤0.01% | 1491 |
|
|
2020
Q1 | – | Sell |
-17,006
| Closed | -$1.05M | – | 1289 |
|
|
2019
Q4 | $1.05M | Hold |
17,006
| – | – | 0.01% | 882 |
|
|
2019
Q3 | $1.24M | Hold |
17,006
| – | – | 0.01% | 798 |
|
|
2019
Q2 | $1.4M | Sell |
17,006
-1,290
| -7% | -$106K | 0.01% | 720 |
|
|
2019
Q1 | $1.29M | Sell |
18,296
-3,930
| -18% | -$277K | 0.01% | 768 |
|
|
2018
Q4 | $1M | Sell |
22,226
-6,731
| -23% | -$303K | 0.01% | 744 |
|
|
2018
Q3 | $1.64M | Buy |
28,957
+8,598
| +42% | +$486K | 0.01% | 756 |
|
|
2018
Q2 | $1.36M | Buy |
20,359
+4,302
| +27% | +$287K | 0.01% | 713 |
|
|
2018
Q1 | $935K | Hold |
16,057
| – | – | 0.01% | 799 |
|
|
2017
Q4 | $1.04M | Hold |
16,057
| – | – | 0.01% | 795 |
|
|
2017
Q3 | $843K | Hold |
16,057
| – | – | 0.01% | 847 |
|
|
2017
Q2 | $751K | Buy |
16,057
+4,143
| +35% | +$194K | 0.01% | 856 |
|
|
2017
Q1 | $590K | Buy |
11,914
+1,961
| +20% | +$97.1K | 0.01% | 1002 |
|
|
2016
Q4 | $603K | Buy |
+9,953
| New | +$603K | 0.01% | 994 |
|